ORBIMED ISRAEL GP LTD. sold 13.1% of their position (336.90K shares) of CHEMOMAB THERAPEUTICS LTD. on the open market
Open‑market sale worth $1.21M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/5/2023ACC: 0000947871-23-000015
10% Owner
Since Mar 2021
-336.90K
Net shares
Net seller
$1.21M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
336.90K disposed
Non-Derivative Transactions2
American Depository Shares
Indirect
Shares
−266.38K
Price / share
$3.34
Trade value
$889.70K
% of position
10.3%
1/3/2023
2.58M→2.31M
American Depository Shares
Indirect
Shares
−70.52K
Price / share
$4.51
Trade value
$318.06K
% of position
3.1%
1/3/2023
2.31M→2.24M
Total
Net shares
−336.90K
Net value
-$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depository Shares Indirect | 1/3/2023 | S · Sale | −266.38K | $3.34 | $889.70K | 10.3% | 2.58M | 2.31M |
| American Depository Shares Indirect | 1/3/2023 | S · Sale | −70.52K | $4.51 | $318.06K | 3.1% | 2.31M | 2.24M |
| Total | −336.90K | -$1.21M | ||||||
Derivative Transactions0
No derivative transactions reported